Protalix Biotherapeutics, Inc. PLX 深 滬
等待開盤 10-21 09:30:00 美东时间
2.14
+0.280
+15.05%
華盛通- 最 高2.15
- 今 開1.87
- 成交量 145.56万股
- 最 低 1.82
- 昨 收 1.86
- 總市值 1.71亿
- 52周最高 3.10
- 市盈率 靜 58.47
- 換手率 1.83%
- 52周最低 1.07
- 委 比 60.00%
- 總股本 7973.21万
- 歷史最高 77.00
- 量 比 0.86
- 振 幅 17.74%
- 歷史最低 0.70
- 每 手 1
- 風險率 0.49%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Why Is Protalix BioTherapeutics Stock Falling On Friday?
EMA issues a negative opinion on Protalix and Chiesi's Elfabrio revised dosing for Fabry disease, citing insufficient data to confirm efficacy.
10-17 23:23
Protalix Faces EMA Setback on Elfabrio® Dosing
Protalix ( ($PLX) ) has issued an announcement. On October 17, 2025, Protalix B...
10-17 20:27
Vantage Drilling International Ltd. Announces Contract for Platinum Explorer
Dubai, Sept. 09, 2025 (GLOBE NEWSWIRE) -- Vantage Drilling International Ltd. (...
09-09 23:06
Protalix BioTherapeutics Q2 Sales $15.658M Beat $13.546M Estimate
Protalix BioTherapeutics (AMEX:PLX) reported quarterly sales of $15.658 million which beat the analyst consensus estimate of $13.546 million by 15.59 percent. This is a 16.21 percent increase over sales of $13.474
08-14 18:51
Earnings Scheduled For August 14, 2025
Companies Reporting Before The Bell • Sunlands Technology (NYSE:STG) is likely ...
08-14 16:32
Protalix BioTherapeutics Q2 Earnings Preview
Protalix BioTherapeutics (NYSE:PLX) is scheduled to announce Q2 earnings results on Thursday, August 14th, before market open. The consensus EPS Estimate is $0.03 and the consensus Revenue Estimate is...
08-14 01:11
Protalix Lawsuit Dismissed After Bylaws Amendment
Protalix ( ($PLX) ) has provided an update. On August 1, 2025, Protalix BioTher...
08-02 05:09
美股代币化的流动性思考：链上交易逻辑该如何重建？
文章来源：Odaily星球日报 6 月底以来，Crypto 行业掀起了一场‘美股上链’热潮，Robinhood、Kraken 等相继推出代币化版本的美国...
07-23 10:00
Protalix Appoints New CFO to Boost Growth Strategy
Protalix ( ($PLX) ) has provided an update. On July 21, 2025, Protalix BioThera...
07-21 21:51
Protalix BioTherapeutics appoints Gilad Mamlok as CFO
Protalix BioTherapeutics (NYSE:PLX) Monday announced the appointment of Gilad Mamlok to serve as the company's new Senior Vice President and Chief Financial Officer, effective August 24, succeeding Ey...
07-21 19:00
